A little research on PDFF suggests that perhaps hepafat scan is not going to amount to all that much. Hence PDFF being the next target of development for RHT.
So a measure of FAT fraction to replace a measure for liver fat fraction both using MRI. And as far as im aware Hepafatscan has produced negligible to no income since its FDA approval in JANUARY 2013.
Been invested in RHT since 2006.
Chart, page-1588
-
- There are more pages in this discussion • 1,988 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RHT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $24.57M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 200000 | 5.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.6¢ | 116743 | 2 |
View Market Depth
| Last trade - 16.12pm 12/07/2024 (20 minute delay) ? |
| RHT (ASX) Chart |
Day chart unavailable